UPDATE 1-Merck's diabetes drug Januvia succeeds in heart safety trial

April 27 (Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a cloud of uncertainty from its biggest product.